Induction of bone formation by Escherichia coli-expressed recombinant human bone morphogenetic protein-2 using block-type macroporous biphasic calcium phosphate in orthotopic and ectopic rat models.

BACKGROUND AND OBJECTIVE The potential of the Escherichia coli-expressed recombinant human bone morphogenetic protein-2 (ErhBMP-2) to support new bone formation/maturation using a block-type of macroporous biphasic calcium phosphate (bMBCP) carrier was evaluated in an orthotopic and ectopic rat model. MATERIAL AND METHODS Critical-size (Φ 8 mm) calvarial defects and subcutaneous pockets in 32 Sprague-Dawley rats received implants of rhBMP-2 (2.5 μg) in a bMBCP carrier or bMBCP alone (control). Implant sites were evaluated using histological and histometric analysis following 2- and 8-wk healing intervals (eight animals/group/interval). RESULTS   ErhBMP-2/bMBCP supported significantly greater bone formation at 2 and 8 wk (10.8% and 25.4%, respectively) than the control at 2 and 8 wk (5.3% and 14.0%, respectively) in calvarial defects (p < 0.01). Bone formation was only observed for the ErhBMP-2/bMBCP ectopic sites and was significantly greater at 8 wk (7.5%) than at 2 wk (4.5%) (p < 0.01). Appositional and endochondral bone formation was usually associated with a significant increase in fatty marrow at 8 wk. The bMBCP carrier showed no evidence of bioresorption. CONCLUSION ErhBMP-2/bMBCP induced significant bone formation in both calvarial and ectopic sites. Further study appears to be required to evaluate the relevance of the bMBCP carrier.

[1]  C. Colnot,et al.  Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. , 2010, Bone.

[2]  Ji‐Hyun Lee,et al.  The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. , 2010, Biomaterials.

[3]  R. Marx,et al.  Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[4]  Maryam Tabrizian,et al.  Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery , 2009, Biotechnology Letters.

[5]  T. He,et al.  A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. , 2009, Stem cells and development.

[6]  G. Churchill,et al.  PPARγ2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells , 2009, Journal of cellular biochemistry.

[7]  Seong-Ho Choi,et al.  Histologic and clinical evaluation for maxillary sinus augmentation using macroporous biphasic calcium phosphate in human. , 2008, Clinical oral implants research.

[8]  F. Schwarz,et al.  Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: an immunohistochemical study in dogs. , 2008, Clinical oral implants research.

[9]  Kyoo-Sung Cho,et al.  Purification and biological activity of recombinant human bone morphogenetic protein-2 produced by E. coli expression system , 2008 .

[10]  G. Daculsi,et al.  Bone tissue formation in sheep muscles induced by a biphasic calcium phosphate ceramic and fibrin glue composite , 2008, Journal of materials science. Materials in medicine.

[11]  Seong-Ho Choi,et al.  The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. , 2006, Biomaterials.

[12]  Pierre Layrolle,et al.  Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. , 2006, Biomaterials.

[13]  Myron Nevins,et al.  De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. , 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[14]  H. Seeherman,et al.  Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. , 2005, Cytokine & growth factor reviews.

[15]  Seong-Ho Choi,et al.  Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. , 2005, Biomaterials.

[16]  J. Fiorellini,et al.  Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. , 2005, Journal of periodontology.

[17]  A. Parfitt,et al.  Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. , 2005, Endocrinology.

[18]  D. Miao,et al.  Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. , 2004, The Journal of endocrinology.

[19]  Kozo Nakamura,et al.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. , 2004, The Journal of clinical investigation.

[20]  A. Zomorodipour,et al.  Heat-Induced Production of Human Growth Hormone by High Cell Density Cultivation of Recombinant Escherichia Coli , 2004, Biotechnology Letters.

[21]  U. Rinas,et al.  Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. , 2002, Journal of biotechnology.

[22]  K. Bessho,et al.  Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. , 2000, The British journal of oral & maxillofacial surgery.

[23]  U. Wikesjö,et al.  Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. , 2000, Journal of periodontology.

[24]  W. Sebald,et al.  Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. , 1998, International journal of oral and maxillofacial surgery.

[25]  W. Sebald,et al.  Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.

[26]  Henning Schliephake,et al.  Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid--an experimental study in rats. , 2008, Biomaterials.